X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2904) 2904
Publication (191) 191
Book Review (20) 20
Conference Proceeding (5) 5
Book Chapter (2) 2
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2594) 2594
male (1673) 1673
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1546) 1546
mice (1445) 1445
neurosciences (1439) 1439
parkinson's disease (1242) 1242
mptp (1145) 1145
mice, inbred c57bl (944) 944
dopamine - metabolism (903) 903
index medicus (811) 811
disease models, animal (761) 761
parkinsons-disease (754) 754
dopamine (735) 735
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology (725) 725
rats (581) 581
female (532) 532
corpus striatum - drug effects (531) 531
corpus striatum - metabolism (531) 531
substantia-nigra (514) 514
neurons (508) 508
humans (474) 474
substantia nigra - drug effects (460) 460
tyrosine 3-monooxygenase - metabolism (427) 427
parkinson disease, secondary - chemically induced (397) 397
brain (392) 392
pharmacology & pharmacy (387) 387
neurons - drug effects (380) 380
oxidative stress (375) 375
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mptp (374) 374
neurotoxicity (363) 363
substantia nigra - metabolism (358) 358
substantia nigra (336) 336
biochemistry & molecular biology (325) 325
motor activity - drug effects (305) 305
brain - metabolism (304) 304
dose-response relationship, drug (300) 300
brain - drug effects (289) 289
substantia nigra - pathology (289) 289
analysis (288) 288
neurons - metabolism (275) 275
neurology (274) 274
time factors (273) 273
striatum (264) 264
dopaminergic-neurons (261) 261
neuroprotective agents - pharmacology (258) 258
clinical neurology (255) 255
neurodegeneration (248) 248
immunohistochemistry (238) 238
behavior, animal - drug effects (234) 234
parkinson’s disease (230) 230
neuroprotection (227) 227
parkinsons disease (222) 222
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - administration & dosage (219) 219
basal ganglia (213) 213
parkinson disease - metabolism (213) 213
dopamine agents - pharmacology (212) 212
parkinsonism (212) 212
3,4-dihydroxyphenylacetic acid - metabolism (198) 198
mpp (196) 196
disease (194) 194
parkinsonian disorders - chemically induced (193) 193
macaca fascicularis (192) 192
mouse model (188) 188
nervous system (182) 182
neurons - pathology (180) 180
mouse (178) 178
mptp poisoning (178) 178
parkinsonian disorders - physiopathology (176) 176
corpus striatum - pathology (174) 174
parkinsonian disorders - metabolism (174) 174
rat (173) 173
parkinson disease - drug therapy (171) 171
pyridines - pharmacology (171) 171
1-methyl-4-phenylpyridinium (167) 167
parkinson disease - pathology (166) 166
apoptosis (165) 165
in-vivo (158) 158
neurodegenerative diseases (158) 158
homovanillic acid - metabolism (155) 155
rat-brain (153) 153
alpha-synuclein (152) 152
parkinson disease, secondary - physiopathology (151) 151
parkinsonian disorders - drug therapy (151) 151
mptp poisoning - metabolism (150) 150
parkinson disease, secondary - metabolism (149) 149
neurotoxins - pharmacology (145) 145
parkinsonian disorders - pathology (144) 144
toxicity (144) 144
tyrosine hydroxylase (142) 142
cell biology (140) 140
dopamine - physiology (140) 140
dopaminergic neurons - drug effects (135) 135
l-dopa (135) 135
macaca mulatta (134) 134
monkeys (134) 134
mptp poisoning - pathology (133) 133
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - adverse effects (132) 132
pyridines - toxicity (132) 132
rats, sprague-dawley (132) 132
levodopa - pharmacology (130) 130
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2846) 2846
Russian (35) 35
Japanese (11) 11
Chinese (6) 6
Spanish (3) 3
French (2) 2
Hungarian (2) 2
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Neurotoxicity Research, ISSN 1029-8428, 7/2018, Volume 34, Issue 1, pp. 47 - 61
Several studies have shown that intrastriatal application of 1-methyl-4-phenylpyridinium (MPP+) produces similar biochemical changes in rat to those seen in... 
Neurochemistry | Neuroprotection | Neurosciences | Dopamine | Neurobiology | Tyrosine hydroxylase | Cell Biology | Neurology | Biomedicine | Carboxyl-terminal domain of tetanus toxin | 1-Methyl-4-phenylpyridinium | Pharmacology/Toxicology | Parkinson’s disease | Parkinson's disease | NEUROTROPHIC FACTOR | PROJECTION NEURONS | DOPAMINE TRANSPORTER | NEUROSCIENCES | RAT MODEL | DENDRITIC SPINE LOSS | HEAVY-CHAIN | INTRAMUSCULAR INJECTION | MOTOR BEHAVIOR | C-TERMINAL DOMAIN | PARKINSONS-DISEASE | Dopamine Plasma Membrane Transport Proteins - metabolism | Synaptosomes - drug effects | Tyrosine 3-Monooxygenase - metabolism | Substantia Nigra - pathology | Male | Synaptosomes - metabolism | Corpus Striatum - metabolism | Corpus Striatum - ultrastructure | Dose-Response Relationship, Drug | Time Factors | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacokinetics | Functional Laterality - drug effects | MPTP Poisoning - pathology | Neuroprotective Agents - administration & dosage | Dopamine - metabolism | Disease Models, Animal | Drug Administration Routes | Movement - drug effects | 3,4-Dihydroxyphenylacetic Acid - metabolism | Drug Administration Schedule | Peptide Fragments - administration & dosage | Dopamine - pharmacokinetics | Rats | Tetanus Toxin - therapeutic use | MPTP Poisoning - prevention & control | Rats, Sprague-Dawley | Substantia Nigra - drug effects | Animals | Homovanillic Acid - metabolism | Analysis of Variance | Tetanus Toxin - administration & dosage | Corpus Striatum - drug effects | Peptide Fragments - therapeutic use | Tritium - pharmacokinetics | Index Medicus
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 02/2011, Volume 17, Issue 5, pp. 489 - 507
Journal Article
Brain Research, ISSN 0006-8993, 2013, Volume 1513, pp. 103 - 116
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 12/2006, Volume 24, Issue 11, pp. 3174 - 3182
Numerous factors contribute to substantia nigra pars compacta (SNc) dopamine (DA) neuron death in Parkinson's disease (PD), thus complicating the search for... 
Parkinsonism | mouse | MPTP | dopamine | Dopamine | Mouse | NEURONAL APOPTOSIS | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL | MPTP-TREATED MICE | SUBSTANTIA-NIGRA | NEUROSCIENCES | LEVODOPA THERAPY | CELL-DEATH | GM1 GANGLIOSIDE TREATMENT | STRIATAL DOPAMINE | CLINICAL-TRIALS | DISEASE PROGRESSION | Neurons - pathology | Tyrosine 3-Monooxygenase - metabolism | Substantia Nigra - pathology | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - administration & dosage | Antigens, Nuclear - metabolism | Drug Evaluation, Preclinical - standards | MPTP Poisoning - physiopathology | Nerve Degeneration - physiopathology | Male | Substantia Nigra - metabolism | Corpus Striatum - metabolism | Nerve Degeneration - chemically induced | Dose-Response Relationship, Drug | Neuroprotective Agents - pharmacology | Parkinsonian Disorders - drug therapy | Neurons - metabolism | Neurons - drug effects | Corpus Striatum - pathology | Dopamine - metabolism | Disease Models, Animal | Biomarkers - metabolism | Drug Evaluation, Preclinical - methods | Parkinsonian Disorders - physiopathology | Drug Administration Schedule | Benzothiazoles - pharmacology | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - adverse effects | Mice, Inbred C57BL | Axons - drug effects | Axons - metabolism | Parkinsonian Disorders - chemically induced | Nerve Tissue Proteins - metabolism | Substantia Nigra - drug effects | Animals | Axons - pathology | Corpus Striatum - drug effects | Mice | Niacinamide - pharmacology | Nerve Degeneration - drug therapy
Journal Article
Experimental Neurology, ISSN 0014-4886, 2007, Volume 208, Issue 1, pp. 120 - 126
Epidemiological studies suggest that some pesticides might constitute a risk factor for Parkinson's disease (PD). However, risk assessment cannot be performed... 
Intranasal delivery | Parkinson's disease | Pesticides | intranasal delivery | POPULATION | RISK | SUBSTANTIA-NIGRA | NEUROSCIENCES | DELIVERY | NIGROSTRIATAL DOPAMINERGIC SYSTEM | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | pesticides | MPTP | EXPOSURE | BRAIN | Neurons - pathology | Substantia Nigra - pathology | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - administration & dosage | Motor Activity - drug effects | Male | Substantia Nigra - metabolism | Corpus Striatum - metabolism | Nerve Degeneration - chemically induced | Herbicides - administration & dosage | Insecticides - administration & dosage | Parkinson Disease, Secondary - pathology | Rotenone - pharmacology | Neurons - metabolism | Parkinson Disease, Secondary - chemically induced | Paraquat - pharmacology | Corpus Striatum - pathology | Dopamine - metabolism | Disease Models, Animal | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology | Insecticides - pharmacology | 3,4-Dihydroxyphenylacetic Acid - metabolism | Drug Administration Schedule | Mice, Inbred C57BL | Administration, Inhalation | Rats | Rotenone - administration & dosage | Herbicides - pharmacology | Administration, Intranasal | Rats, Sprague-Dawley | Nerve Degeneration - pathology | Paraquat - administration & dosage | Substantia Nigra - drug effects | Animals | Parkinson Disease, Secondary - physiopathology | Corpus Striatum - drug effects | Mice | Herbicides | Insecticidal plants
Journal Article
Neurotoxicity Research, ISSN 1029-8428, 4/2018, Volume 33, Issue 3, pp. 549 - 559
Journal Article
Journal Article
Journal Article